Hubbard Cristin (CIK 2021836) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-21). Recent activity: Sell BMRN (2,318 shares), Buy BMRN (15,410 shares), Sell BMRN (1,245 shares), Buy BMRN (80 shares), Sell BMRN (2,155 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-21 | BIOMARIN PHARMACEUTICAL INC (BMRN) | EVP, Chief Commercial Officer | Sell | 2,318 | $116,364 |
| 2026-03-18 | BIOMARIN PHARMACEUTICAL INC (BMRN) | EVP, Chief Commercial Officer | Buy | 15,410 | $0 |
| 2026-03-18 | BIOMARIN PHARMACEUTICAL INC (BMRN) | EVP, Chief Commercial Officer | Sell | 1,245 | $69,782 |
| 2026-02-13 | BIOMARIN PHARMACEUTICAL INC (BMRN) | EVP, Chief Commercial Officer | Buy | 80 | $3,643 |
| 2025-05-22 | BIOMARIN PHARMACEUTICAL INC (BMRN) | EVP, Chief Commercial Officer | Sell | 2,155 | $129,149 |
| 2025-05-06 | BIOMARIN PHARMACEUTICAL INC (BMRN) | EVP, Chief Commercial Officer | Buy | 273 | $14,780 |
| 2025-05-06 | BIOMARIN PHARMACEUTICAL INC (BMRN) | EVP, Chief Commercial Officer | Sell | 273 | $17,723 |
| 2025-03-18 | BIOMARIN PHARMACEUTICAL INC (BMRN) | EVP, Chief Commercial Officer | Buy | 13,310 | $0 |
Source: SEC Form 4 filings · as of 2026-05-21